Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Snail secretion cream may speed skin recovery after laser

NCT ID NCT07442422

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a skincare cream containing a snail-derived ingredient (SCA) to see if it helps facial skin heal faster after a laser treatment. Twenty-four adults received the active cream on one side of their face and a plain moisturizer on the other. The researchers measured healing by looking at skin under a special microscope and checking for redness, moisture loss, and pigment changes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a skincare cream containing 40% secretion of SCA (a snail-derived ingredient)
What this could lead to
If it works, this could point toward a way to speed up skin healing and reduce redness or pigment changes after laser procedures.
What could go wrong
This was a very small, early study with only 24 people. The results may not apply to everyone, and the product is only for recovery after a specific laser treatment, not a cure for any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Apr 2023

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Individuals aged 30-65 years; 2. Candidates for ablative fractional laser treatment on the face; 3. Agree to undergo photographic documentation before and after the ablative fractional laser procedure and during follow-up visits; 4. Refrain from using other similar products (except facial cleansers) after ablative fractional laser treatment; 5. Written informed consent obtained. Exclusion Criteria: 1. known hypersensitivity to product ingredients; 2. active skin infections; 3. history of keloid formation; 4. immunosuppressive therapy and pregnancy or lactation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laser treatment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huashan Hospital

    Shanghai, Shanghai Municipality, 200040, China